Subscribe
As someone who lives with the long-term effects of chikungunya, Camillo Mora PhD, sees the expanding habitat of mosquitos and is concerned more people will be exposed to vector-borne illnesses and deal with not only the acute phases of these viruses but also the possibility of long-term health effects they can present.
First Dengue Vaccine Approved in the European Union
Lyme Disease Vaccine Shows Antibodies 6 Months after Completion
FDA Grants Priority Review for Investigational Dengue Vaccine
Positive Phase 1 Data Reported for Dengue Antiviral
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Tiffany A. Traina, MD, FASCO
Ana C. Garrido-Castro, MD; Pedram Razavi, MD, PhD
Joyce O’Shaughnessy, MD
Kamel Abou Hussein, MD; Yelda Nouri, MD